Interpace Biosciences, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2015 | 26.7% | -428.4% | -144.4% |
| FY2016 | 49.2% | -49.2% | -168.2% |
| FY2017 | 53.7% | -39.6% | 79.0% |
| FY2018 | 53.4% | -57.7% | -58.0% |
| FY2019 | 34.4% | -109.1% | -110.4% |
| FY2020 | 33.1% | -80.5% | -81.6% |
| FY2021 | 229.4% | -77.3% | -182.3% |
| FY2022 | 321.1% | -63.7% | -386.7% |
| FY2023 | 62.6% | 9.9% | 4.9% |
| FY2024 | 63.8% | 17.3% | 14.3% |